PMID- 23638101 OWN - NLM STAT- MEDLINE DCOM- 20131209 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 4 DP - 2013 TI - Differential susceptibility and response of primary human myeloid BDCA1(+) dendritic cells to infection with different Enteroviruses. PG - e62502 LID - 10.1371/journal.pone.0062502 [doi] LID - e62502 AB - Coxsackie B viruses (CVBs) and echoviruses (EVs) form the Human Enterovirus-B (HEV-B) species within the family Picornaviridae. HEV-B infections are widespread and generally cause mild disease; however, severe infections occur and HEV-B are associated with various chronic diseases such as cardiomyopathy and type 1 diabetes. Dendritic cells (DCs) are the professional antigen-presenting cells of our immune system and initiate and control immune responses to invading pathogens, yet also maintain tolerance to self-antigens. We previously reported that EVs, but not CVBs, can productively infect in vitro generated monocyte-derived DCs. The interactions between HEV-B and human myeloid DCs (mDCs) freshly isolated from blood, however, remain unknown. Here, we studied the susceptibility and responses of BDCA1(+) mDC to HEV-B species and found that these mDC are susceptible to EV, but not CVB infection. Productive EV7 infection resulted in massive, rapid cell death without DC activation. Contrary, EV1 infection, which resulted in lower virus input at the same MOI, resulted in DC activation as observed by production of type I interferon-stimulated genes (ISGs), upregulation of co-stimulatory and co-inhibitory molecules (CD80, CD86, PDL1) and production of IL-6 and TNF-alpha, with a relative moderate decrease in cell viability. EV1-induced ISG expression depended on virus replication. CVB infection did not affect DC viability and resulted in poor induction of ISGs and CD80 induction in part of the donors. These data show for the first time the interaction between HEV-B species and BDCA1(+) mDCs isolated freshly from blood. Our data indicate that different HEV-B species can influence DC homeostasis in various ways, possibly contributing to HEV-B associated pathology. FAU - Schulte, Barbara M AU - Schulte BM AD - Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences & Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. FAU - Kers-Rebel, Esther D AU - Kers-Rebel ED FAU - Prosser, Amy C AU - Prosser AC FAU - Galama, Jochem M D AU - Galama JM FAU - van Kuppeveld, Frank J M AU - van Kuppeveld FJ FAU - Adema, Gosse J AU - Adema GJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130424 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Antigens, CD1) RN - 0 (Antigens, Surface) RN - 0 (CD1C protein, human) RN - 0 (Glycoproteins) RN - 0 (Interferon-alpha) RN - 0 (Toll-Like Receptors) RN - 77238-31-4 (Interferon-beta) SB - IM MH - Antigens, CD1 MH - Antigens, Surface/*metabolism MH - Cell Death MH - Cell Differentiation/immunology MH - Cytopathogenic Effect, Viral MH - Dendritic Cells/cytology/immunology/*metabolism/*virology MH - Enterovirus/immunology/*physiology MH - Glycoproteins MH - Humans MH - Interferon-alpha/biosynthesis/immunology MH - Interferon-beta/biosynthesis/immunology MH - Myeloid Cells/immunology/*metabolism/*virology MH - Toll-Like Receptors/metabolism MH - Virus Replication PMC - PMC3634769 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/05/03 06:00 MHDA- 2013/12/16 06:00 PMCR- 2013/04/24 CRDT- 2013/05/03 06:00 PHST- 2012/12/14 00:00 [received] PHST- 2013/03/22 00:00 [accepted] PHST- 2013/05/03 06:00 [entrez] PHST- 2013/05/03 06:00 [pubmed] PHST- 2013/12/16 06:00 [medline] PHST- 2013/04/24 00:00 [pmc-release] AID - PONE-D-12-39561 [pii] AID - 10.1371/journal.pone.0062502 [doi] PST - epublish SO - PLoS One. 2013 Apr 24;8(4):e62502. doi: 10.1371/journal.pone.0062502. Print 2013.